Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Maintenance ECT Versus Clozapine in Treatment-resistant Schizophrenia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients clinically diagnosed with treatment-resistant schizophrenia (TRS) (TRRIP consensus criteria).~* Patients aged 18-60 years of either sex.~* Patients giving voluntary written consent for participation in the study~Exclusion Criteria:~* Patient already on Clozapine or ECT.~* History of psychoactive substance abuse or dependence.~* Co-morbid psychiatric, major medical, or neurological disorders.~* History of organicity or significant head injury.~* Pacemaker or metal in any part of the body excluding the mouth.~* Pregnant and breastfeeding females.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Test group (Type: EXPERIMENTAL): Bilateral Maintenance ECT (B/L M-ECT)
- Control group (Type: ACTIVE_COMPARATOR): Clozapine monotherapy. Clozapine will be given in accordance with Maudsley guideline: 12.5 mg on the first day, followed by 12.5mg twice daily on the second day, followed by 25mg twice daily for next two days and then increment of 25mg every two days till the target dose of 250-400 mg per day in two divided doses as per tolerability of the patients

Based on this trial design, predict the completion outcome and termination type (if applicable).